Quince Therapeutics, Inc. – Particular Name

Andrew Fein
H.C. Wainwright & Co, LLC, Analysis Division

Good morning, everybody. I am Andrew Fein. I am one of many biotechnology analysis analyst at H.C. Wainwright. It is my pleasure this morning to host a HCW @ Residence occasion, regardless that a lot of you most likely aren’t at dwelling, with Quince Therapeutics. Right here from the corporate are its CEO and Chief Medical Officer, Dirk Thye; and Brendan Hannah, its Chief Working Officer and Chief Enterprise Officer.

So thanks each very a lot for being right here this morning. We respect it. And possibly with that, one of the best place to form of kick off is for individuals much less conversant in the story, possibly you can provide an outline and form of converse to your concentrate on uncommon ailments, after which we’ll go from there.

Dirk Thye
CEO, Chief Medical Officer & Director

Positive. Thanks, Andrew. That is Dirk Thye right here. I am the CEO and the Chief Medical Officer, and the identify of the corporate is Quince Therapeutics. We have now a drug system mixture, which is a platform know-how. It is a machine, a tabletop machine that takes blood a small quantity of blood from a affected person, 50 mills, so in regards to the quantity of double espresso. You are taking that quantity of blood in a syringe, you hook it as much as the machine and also you course of the blood to encapsulate a molecule within the sufferers on purple blood cells. So it takes a small quantity of autologous blood and also you’re able to placing a drug, a small molecule, a big molecule or perhaps a protein within the affected person’s purple blood cells.